A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL343 in Healthy Volunteers
Clinical trial NCT04268784 · COMPLETED
Trial details
- NCT number
- NCT04268784
- Sponsor
- Denali Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2021-08-03
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.